ArticleCancer gene therapy2026
NAT10 promotes prostate cancer progression by acetylating mRNA of MARK2 and activating mTOR/HIF-1α/C-Myc pathway to enhance glycolytic reprogramming.
Yiming Zhang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.